LUNG

Pulmonx Corporation Common Stock

1.30

USD

LUNG Earnings Reports

Positive Surprise Ratio

LUNG beat 21 of 22 last estimates.

95%

Next Report

Date of Next Report

Apr 28, 2026

Estimate for Q1 26 (Revenue/ EPS)

$20.84M

-$0.33

Implied change from Q4 25 (Revenue/ EPS)

-7.78%

+32.00%

Implied change from Q1 25 (Revenue/ EPS)

-7.53%

-8.33%

Pulmonx Corporation Common Stock earnings per share and revenue

On Mar 04, 2026, LUNG reported earnings of -0.25 USD per share (EPS) for Q4 25, beating the estimate of -0.39 USD, resulting in a 37.47% surprise. Revenue reached 22.60 million, compared to an expected 22.16 million, with a 1.96% difference. The market reacted with a +11.81% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 20.84 million USD, implying an increase of 32.00% EPS, and decrease of -7.78% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

KORU Medical Systems, Inc. Common Stock (DE)

Report Date

Mar 12, 2026 For Q4 25

Estimate

Actual

-$0.01

Surprise

CareCloud, Inc. Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

$0.03

Actual

$0.03

Surprise

-15.97%

Nyxoah SA Ordinary Shares

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.55

Actual

-$0.58

Surprise

-5.51%

Health Catalyst, Inc Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

$0.09

Actual

$0.08

Surprise

-13.79%

Neuraxis, Inc.

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.21

Actual

-$0.17

Surprise

+22.48%

Heartflow, Inc. Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.17

Actual

-$0.12

Surprise

+30.31%

Heartbeam, Inc. Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.13

Actual

-$0.14

Surprise

-0.72%

HeartSciences Inc. Common Stock

Report Date

Mar 16, 2026 For Q3 26

Estimate

-$0.86

Actual

-$0.63

Surprise

+27.34%

FAQ

What were Pulmonx Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Pulmonx Corporation Common Stock reported EPS of -$0.25, beating estimates by 37.47%, and revenue of $22.60M, 1.96% above expectations.

How did the market react to Pulmonx Corporation Common Stock's Q4 2025 earnings?

The stock price moved up 11.81%, changed from $1.44 before the earnings release to $1.61 the day after.

When is Pulmonx Corporation Common Stock expected to report next?

The next earning report is scheduled for Apr 28, 2026.

What are the forecasts for Pulmonx Corporation Common Stock's next earnings report?

Based on 8 analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.33 and revenue of $20.84M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.